CA9 and glioblastoma: Therefore, in the search for other suitable markers of hypoxia in GBM, we compared the expression of CA9 (Figure S1e) and GSC marker CD44 [15] in the same anatomic features, as it was proposed in the human and a mouse model of GBM that perivascular and perinecrotic zones are GSC-enriched [15,36,37].